Author:
Wang Bohui,Wu Haixing,Shao Mingyang,Jiang Mengqi,Su Ruiheng,Gao Xia,Xia Guanghua,Shi Haohao,Shen Xuanri
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Adhikary, B., Yadav, S. K., Roy, K., Bandyopadhyay, S. K., and Chattopadhyay, S., 2011. Black tea and theaflavins assist healing of indomethacin-induced gastric ulceration in mice by antioxidative action. Evidence-Based Complementary and Alternative Medicine, 2011: 546560, DOI: https://doi.org/10.1155/2011/546560.
2. Baumgart, M., Luder, K., Grover, S., Gätgens, C., Besra, G. S., and Frunzke, J., 2013. IpsA, a novel LacI-type regulator, is required for inositol-derived lipid formation in Corynebacteria and Mycobacteria. BMC Biology, 11: 122, DOI: https://doi.org/10.1186/1741-7007-11-122.
3. Bennett, A., and Villa, G., 2000. Nimesulide: An NSAID that preferentially inhibits COX-2, and has various unique pharmacological activities. Expert Opinion On Pharmacotherapy, 1 (2): 277–286, DOI: https://doi.org/10.1517/14656566.1.2.277.
4. Bijlsma, J. W., 2004. Withdrawal of rofecoxib: A sign to be careful with coxibs in patients with increased cardiovascular risk. Nederlands Tijdschrift voor Geneeskunde, 148 (44): 2162–2164.
5. Bourn, J., and Cekanova, M., 2018. Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitro. Drug Design Development and Therapy, 12: 1727–1742, DOI: https://doi.org/10.2147/dddt.S158518.